Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Solomon

Showing results (121-130 of 1,422) with videos related to

Pageof 143
Sort By:
Lancet (London, England)|January 24, 2021
Considering dose in pharmacological therapies for heart failure - Authors' replyMuthiah Vaduganathan, Gregg C Fonarow, John J V McMurray, et al.
Biometrika|October 11, 2012
Calibrating parametric subject-specific risk estimationT Cai, L Tian, Hajime Uno, et al.
Statistics in Medicine|July 27, 2018
Quantifying the totality of treatment effect with multiple event-time observations in the presence of a terminal event from a comparative clinical studyBrian Claggett, Lu Tian, Haoda Fu, et al.
Journal of the American Heart Association|November 7, 2012
Mortality rates in trials of subjects with type 2 diabetesEbrahim Barkoudah, Hicham Skali, Hajime Uno, et al.
Circulation. Heart Failure|November 22, 2014
Left atrium in heart failure with preserved ejection fraction: structure, function, and significanceAndrea Rossi, Mihai Gheorghiade, Filippos Triposkiadis, et al.
JACC. Cardiovascular Imaging|November 17, 2012
Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failureAmil M Shah, Mikhail Bourgoun, Jagat Narula, et al.
Echocardiography (Mount Kisco, N.Y.)|January 27, 2012
Regional right ventricular strain pattern in patients with acute pulmonary embolismElke Platz, Amira H Hassanein, Amil Shah, et al.
Circulation. Cardiovascular Imaging|October 31, 2015
Right Atrial Function in Pulmonary Arterial HypertensionGabriela Querejeta Roca, Patricia Campbell, Brian Claggett, et al.
European Heart Journal|January 4, 2020
The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in contextJohn J V McMurray, Scott D Solomon, Kieran F Docherty, et al.
Circulation|July 7, 2020
Response by Jackson et al to Letter Regarding Article, "Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF"Alice M Jackson, Pardeep S Jhund, Scott D Solomon, et al.
Pageof 143

Showing results (121-130 of 1,422) with videos related to

Sort By:
Pageof 143
Lancet (London, England)|January 24, 2021
Considering dose in pharmacological therapies for heart failure - Authors' replyMuthiah Vaduganathan, Gregg C Fonarow, John J V McMurray, et al.
Biometrika|October 11, 2012
Calibrating parametric subject-specific risk estimationT Cai, L Tian, Hajime Uno, et al.
Statistics in Medicine|July 27, 2018
Quantifying the totality of treatment effect with multiple event-time observations in the presence of a terminal event from a comparative clinical studyBrian Claggett, Lu Tian, Haoda Fu, et al.
Journal of the American Heart Association|November 7, 2012
Mortality rates in trials of subjects with type 2 diabetesEbrahim Barkoudah, Hicham Skali, Hajime Uno, et al.
Circulation. Heart Failure|November 22, 2014
Left atrium in heart failure with preserved ejection fraction: structure, function, and significanceAndrea Rossi, Mihai Gheorghiade, Filippos Triposkiadis, et al.
JACC. Cardiovascular Imaging|November 17, 2012
Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failureAmil M Shah, Mikhail Bourgoun, Jagat Narula, et al.
Echocardiography (Mount Kisco, N.Y.)|January 27, 2012
Regional right ventricular strain pattern in patients with acute pulmonary embolismElke Platz, Amira H Hassanein, Amil Shah, et al.
Circulation. Cardiovascular Imaging|October 31, 2015
Right Atrial Function in Pulmonary Arterial HypertensionGabriela Querejeta Roca, Patricia Campbell, Brian Claggett, et al.
European Heart Journal|January 4, 2020
The Dapagliflozin and Prevention of Adverse outcomes in Heart Failure trial (DAPA-HF) in contextJohn J V McMurray, Scott D Solomon, Kieran F Docherty, et al.
Circulation|July 7, 2020
Response by Jackson et al to Letter Regarding Article, "Effects of Sacubitril-Valsartan Versus Valsartan in Women Compared With Men With Heart Failure and Preserved Ejection Fraction: Insights From PARAGON-HF"Alice M Jackson, Pardeep S Jhund, Scott D Solomon, et al.
Pageof 143